WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Pharmaceutical Exporter from India to Bangladesh.

Bangladesh has a strong domestic pharmaceutical industry: the US International Trade Administration reports that it meets nearly 98 per cent of the country's domestic demand for pharmaceutical products, and Square, Beximco, Incepta, and Renata are Bangladeshi producers. That reality shapes our Bangladesh desk with unusual honesty. We do not pitch commodity orals into a market that already manufactures them at scale. Instead we focus on the niche where Indian supply can fill gaps, specialised oncology injectables, monoclonal antibodies, complex biologics, and second-line therapies, and we check each line against local supply before we propose it. Mumbai-Chittagong sea freight is short, INR invoicing can be arranged where the importer's bank supports it, and we prepare DGDA dossiers in English.

WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners ISO 9001:2015 SGS GDP Certified Pharmexcil RCMC FIEO Member Cold-chain validated CTD / eCTD ready
Regulatory environment

How DGDA registration works for Indian-origin imports

The Directorate General of Drug Administration, DGDA, sits inside the Bangladesh Ministry of Health and Family Welfare and is the registration gatekeeper for every imported pharmaceutical product. We prepare dossiers in English and in CTD format, and before each filing we confirm DGDA's current document requirements for the product.

DGDA registration for imports needs a full dossier with stability data at the long-term condition DGDA accepts for the product (Bangladesh has not notified WHO of one; WHO's stability table carries an industry estimate of 30°C/65% RH), together with manufacturer documentation, and we confirm the current checklist for each product before filing. Our regulatory team in Mumbai handles dossier authoring and our Dhaka-based regulatory consultants run DGDA submission and reviewer liaison.

A practical point for Bangladesh: we check each molecule against what local manufacturers already supply before we propose it, and we concentrate on oncology, biologics, and certain specialised injectables.

Post-marketing variation filings, safety reporting, and registration renewals continue after approval. We track each registered SKU on a renewal calendar and prepare variation paperwork ahead of any planned manufacturing change. We ask our Indian source plants to keep full quality documentation ready for inspection.

Call & WhatsApp the Mumbai desk: +91 70156 05768 · [email protected] · Mon–Sat 09:30–18:30 IST

What we do for Bangladeshi customers

Where the Bangladesh desk concentrates effort

DGDA dossier authoring

Complete CTD dossier compilation in English, with Bangladesh-specific Module 1 content, the manufacturer's GMP certificate package, and stability data at the condition DGDA accepts for the product.

Niche-category focus

Oncology injectables, monoclonal antibodies, complex biologics, and second-line therapies, selected line by line against local supply.

CMSD tender response

Pricing models, COA bundles, and technical compliance for Central Medical Stores Depot procurement into government hospitals.

Cold-chain biologics

Validated 2-8 degree shippers from Mumbai BOM to Dhaka DAC and Chittagong CGP with continuous datalogger output.

INR settlement option

Indian rupee invoicing under the Reserve Bank of India's July 2022 rupee settlement arrangement where the Bangladeshi importer's bank supports it, alongside standard USD invoicing.

Variation and renewal

DGDA variation filings on site, specification, and pack changes, with renewal paperwork started well ahead of expiry.

Mumbai-to-Bangladesh freight

Sea and air routing from Mumbai to Chittagong and Dhaka

Our default sea routing into Bangladesh is Mumbai Nhava Sheva to Chittagong. Chittagong and Mongla together handle over 90 per cent of Bangladesh's international trade, according to the Observer Research Foundation, and Mongla is the second busiest seaport in the country. Transit time depends on the sailing and on whether the service is direct or transhipped, so we quote it per shipment from the carrier's current schedule. The Petrapole-Benapole road border crossing is also available for certain cargo categories where road freight makes commercial sense.

Air freight from BOM and DEL into DAC Hazrat Shahjalal in Dhaka handles cold-chain biologics, narcotic-controlled CNS shipments, and tender-deadline reactive lifts. We confirm routing and transit time per shipment against current airline schedules.

Customs clearance at Chittagong port and Dhaka airport needs complete commercial documentation, and we confirm the full document list with the importer's clearing agent before each shipment. A certificate of origin is added where a tariff preference is claimed. Where the importer's bank supports it, INR invoicing is possible under the Reserve Bank of India's July 2022 arrangement for rupee invoicing and settlement.

Formulary focus

Where Indian supply can add to Bangladeshi supply

Bangladesh's domestic pharmaceutical industry meets nearly 98 per cent of the country's demand for pharmaceutical products, according to the US International Trade Administration. Square Pharmaceuticals, Beximco Pharma, Incepta Pharmaceuticals, and Renata Limited are Bangladeshi producers, and Bangladeshi firms also export. This shapes our Bangladesh formulary with unusual discipline.

Oncology is our strongest Bangladesh category. Cytotoxic injectables, monoclonal antibodies, and supportive-care medicines from EU-GMP Indian plants can supply oncology specialty centres and tertiary hospitals, line by line, for products not already covered by local supply. Biologics including insulin biosimilars, monoclonals, and certain specialised proteins are a growing focus for our desk.

Second-line anti-infectives, complex injectables, and specialised dosage forms fill out the Bangladesh portfolio. We do not pitch commodity oral antibiotics, basic antihypertensives, or routine antidiabetics into Bangladesh, because Square, Beximco, Incepta, Renata, and the wider Bangladeshi industry already supply those categories at scale. That selectivity is a feature, not a limitation, and it is what keeps the Bangladeshi importer base coming back for the categories where we do compete.

A Dhaka-based DGDA-licensed importer specialising in oncology and biologic supply engaged us in 2023 for a portfolio of four monoclonal antibody biosimilars and three cytotoxic injectables targeting tertiary cancer centres in Dhaka and Chittagong. The molecules were specifically those where Bangladeshi domestic capacity is limited and where Indian biosimilar supply offered material price advantage against European originator product. Two of the biosimilars already had CTD dossiers we had filed in Sri Lanka and the Philippines, so our regulatory team adapted those for DGDA submission within roughly four months. The remaining lines required new dossier compilation but proceeded on parallel tracks with Zone IVb stability already in place at our EU-GMP source plants. First commercial container ex-Nhava Sheva landed at Chittagong eleven days after the final DGDA approval letter, with cold-chain dataloggers showing zero excursions and INR-denominated invoicing under the SAARC settlement framework. The importer extended the arrangement to two further oncology supportive-care lines within nine months.

Illustrative operational case Bangladesh · Dhaka oncology specialist importer · Monoclonal antibody biosimilars
Why M Care Exports for Bangladesh

What Bangladeshi importers find different about our approach

Bangladesh is a market where most foreign pharmaceutical exporters either misread the domestic-manufacturing strength entirely or pitch commodity portfolios that go nowhere. We do neither. Our Bangladesh desk has been built around the simple recognition that Square, Beximco, Incepta, and Renata are excellent at what they do, and the realistic Indian opportunity sits in oncology, biologics, and specialised injectables, assessed line by line against local supply. That positioning is honest, and it builds importer relationships that survive because we are not in head-on competition with Bangladeshi giants.

The structural advantages we bring are Mumbai-Chittagong sea freight, English-language DGDA dossier work, EU-GMP source credentials on the categories that matter, and the option of INR invoicing where the importer's bank supports it and the importer prefers to avoid USD exposure. Combined with our Dhaka regulatory consultant network and our experience filing in adjacent South Asian markets including Sri Lanka and Nepal, the Bangladesh desk runs registration and supply cycles that Bangladeshi importers can plan around with confidence.

Bangladesh FAQ

Questions Bangladeshi importers ask before engaging

Does DGDA accept WHO-GMP certification from Indian manufacturers?

We collect from each manufacturer its GMP certificate, manufacturing licence, and recent inspection observations for each DGDA submission, and we confirm DGDA's current document requirements for the product before filing. Many of our source plants additionally hold EU-GMP certification, which we include in the dossier where it applies.

Why do you focus only on niche categories for Bangladesh?

Because Bangladesh's domestic pharmaceutical industry is genuinely strong and meets nearly 98 per cent of the country's demand for pharmaceutical products. Square Pharmaceuticals, Beximco Pharma, Incepta, and Renata are Bangladeshi producers, and a product that local plants already supply gives an importer little reason to look abroad. Pretending otherwise would waste the buyer's time and ours. Our value lies in oncology injectables, monoclonal antibodies, biologics, second-line anti-infectives, and complex specialised injectables, assessed line by line against local supply.

What sea freight transit time should we plan from Mumbai to Chittagong?

Transit time from Mumbai Nhava Sheva to Chittagong depends on the sailing and on whether the service is direct or transhipped, so we quote it per shipment from the carrier's current schedule rather than a fixed figure. Our broker pre-files import documentation while the vessel is still at sea so that clearance can start before the container lands. Cold-chain biologics normally ship by air rather than sea, and we confirm air routing and transit time per shipment.

Can we settle invoices in Indian rupees rather than US dollars?

Yes, where the importer's bank supports it. The Reserve Bank of India's circular of 11 July 2022 allows exports and imports to be denominated and invoiced in Indian rupees under a special rupee vostro account arrangement with correspondent banks of the partner country. We invoice in either USD or INR according to the importer's preference and banking arrangement, and we provide all documentation in the form the Bangladeshi authorised dealer bank requires for the chosen settlement currency.

How long does DGDA registration typically take?

DGDA registration time depends on dossier completeness, queries during review, and the product category, so we do not quote a fixed timeline in advance. Where we have already filed the same molecule in Sri Lanka, the Philippines, or another South Asian or Asian market, we adapt those dossiers for DGDA rather than rewriting from scratch, which shortens the authoring phase.

Is the road border crossing at Petrapole-Benapole a viable freight option?

For certain cargo categories yes. Petrapole in India and Benapole in Bangladesh form a land border crossing used for road freight between the two countries. It can suit non-cold-chain SKUs from eastern Indian source plants destined for Dhaka or northern Bangladesh, but customs procedures, vehicle arrangements at the border, and documentation differ from sea freight, and we do not assume road is quicker. We assess the road option on a case-by-case basis where the source plant location and the cargo profile make it sensible. Most of our Mumbai-origin shipments default to Mumbai-Chittagong sea routing.

How do you handle Bangladeshi political instability and supply continuity?

Political events, strikes, and weather can disrupt ports, borders, and customs processing in any market, and we plan supply continuity accordingly. Our standard practice for time-sensitive shipments includes maintaining buffer stock at the importer's licensed warehouse, splitting consignment volumes across multiple shipments rather than concentrating risk, and using air freight as fallback routing when sea-freight or border conditions are uncertain. We monitor port operations at Chittagong and Mongla, customs processing at Hazrat Shahjalal, and broader transport conditions through our Dhaka logistics partners, and we communicate proactively with importers when conditions warrant rerouting or rescheduling. Cold-chain biologic shipments are scheduled with extra contingency given the consequences of temperature excursion.

Indian pharmaceutical supply built for Bangladesh

Open a niche-category Bangladesh line with realistic scope

Honest niche positioning

Oncology, biologics, and specialised injectables only. We do not pitch commodity orals against Square, Beximco, Incepta, or Renata.

Mumbai-Chittagong short sea

Sea routing from Mumbai Nhava Sheva to Chittagong, with transit time quoted per shipment from the carrier's current schedule.

INR settlement option

Indian rupee invoicing under the Reserve Bank of India's July 2022 arrangement where the Bangladeshi importer's bank supports it.

Shop by therapeutic area

Top categories we ship to Bangladesh

Talk to the Bangladesh desk

Tell us your DGDA niche-category brief

Send the molecule list, the target Bangladeshi channel of CMSD state procurement or private oncology and biologic specialty importer, and any existing CTD dossiers you hold. The Bangladesh desk will respond with a DGDA registration timeline, a Mumbai-Chittagong freight plan, an INR-versus-USD settlement view, and a candid assessment of which lines compete sensibly against Bangladeshi domestic manufacturing. We focus on real niche opportunity, not on trying to displace Square, Beximco, Incepta, or Renata.

Start a Bangladesh enquiry → Back to all markets

Buying for repeat supply? Open a trade account for a named account manager and priced quotes.